Alcon Labs Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ALCON LABS, and what generic alternatives to ALCON LABS drugs are available?
ALCON LABS has eighteen approved drugs.
There are forty US patents protecting ALCON LABS drugs.
There are two hundred and seventeen patent family members on ALCON LABS drugs in thirty-one countries and twenty-seven supplementary protection certificates in ten countries.
Summary for Alcon Labs
| International Patents: | 217 |
| US Patents: | 40 |
| Tradenames: | 15 |
| Ingredients: | 13 |
| NDAs: | 18 |
Drugs and US Patents for Alcon Labs
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alcon Labs Inc | PATADAY TWICE DAILY RELIEF | olopatadine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 020688-001 | Dec 18, 1996 | OTC | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | |||||
| Alcon Labs Inc | RHOPRESSA | netarsudil mesylate | SOLUTION/DROPS;OPHTHALMIC | 208254-001 | Dec 18, 2017 | RX | Yes | Yes | 9,096,569 | ⤷ Sign Up | Y | Y | ⤷ Sign Up | ||
| Alcon Labs Inc | ROCKLATAN | latanoprost; netarsudil dimesylate | SOLUTION/DROPS;OPHTHALMIC | 208259-001 | Mar 12, 2019 | RX | Yes | Yes | 9,096,569 | ⤷ Sign Up | Y | Y | ⤷ Sign Up | ||
| Alcon Labs Inc | ROCKLATAN | latanoprost; netarsudil dimesylate | SOLUTION/DROPS;OPHTHALMIC | 208259-001 | Mar 12, 2019 | RX | Yes | Yes | 10,588,901 | ⤷ Sign Up | Y | Y | ⤷ Sign Up | ||
| Alcon Labs Inc | RHOPRESSA | netarsudil mesylate | SOLUTION/DROPS;OPHTHALMIC | 208254-001 | Dec 18, 2017 | RX | Yes | Yes | 10,532,993 | ⤷ Sign Up | ⤷ Sign Up | ||||
| Alcon Labs Inc | ROCKLATAN | latanoprost; netarsudil dimesylate | SOLUTION/DROPS;OPHTHALMIC | 208259-001 | Mar 12, 2019 | RX | Yes | Yes | 8,394,826 | ⤷ Sign Up | Y | Y | ⤷ Sign Up | ||
| Alcon Labs Inc | EYSUVIS | loteprednol etabonate | SUSPENSION/DROPS;OPHTHALMIC | 210933-001 | Oct 26, 2020 | RX | Yes | Yes | 10,857,096 | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Alcon Labs
International Patents for Alcon Labs Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Japan | 6720443 | ⤷ Sign Up |
| South Korea | 20150006869 | ⤷ Sign Up |
| World Intellectual Property Organization (WIPO) | 2013166408 | ⤷ Sign Up |
| Japan | 2020050663 | ⤷ Sign Up |
| European Patent Office | 3045164 | ⤷ Sign Up |
| Japan | 5980846 | ⤷ Sign Up |
| European Patent Office | 2722035 | ⤷ Sign Up |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Alcon Labs Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 3053913 | C202030018 | Spain | ⤷ Sign Up | PRODUCT NAME: NETARSUDIL O UN ENANTIOMERO, DIASTEREOMERO, SAL O SOLVATO DEL MISMO.; NATIONAL AUTHORISATION NUMBER: EU/1/19/1400; DATE OF AUTHORISATION: 20191119; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/19/1400; DATE OF FIRST AUTHORISATION IN EEA: 20191119 |
| 3461484 | 301101 | Netherlands | ⤷ Sign Up | PRODUCT NAME: LATANOPROST OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN EN NETARSUDILMESYLAAT; REGISTRATION NO/DATE: EU/1/20/1502 20210108 |
| 3461484 | 21C1024 | France | ⤷ Sign Up | PRODUCT NAME: ASSOCIATION DE NETARSUDIL OU L'UN DE SES SELS ET DE LATANOPROST; REGISTRATION NO/DATE: EU/1/20/1502 20210108 |
| 3053913 | 301038 | Netherlands | ⤷ Sign Up | PRODUCT NAME: NETARSUDIL, OF EEN ZOUT OF SOLVAAAT DAARVAN, IN HET BIJZONDER NETARSUDILMESYLAAT; REGISTRATION NO/DATE: EU/1/19/1400 20191121 |
| 3461484 | SPC/GB21/033 | United Kingdom | ⤷ Sign Up | PRODUCT NAME: A COMBINATION OF LATANOPROST AND NETARSUDIL; REGISTERED: UK EU/1/20/1502(FOR NI) 20210107; UK PLGB 16053/0034 20210107 |
| 3053913 | 2020C/510 | Belgium | ⤷ Sign Up | PRODUCT NAME: RHOKIINSA - NETARSUDIL; AUTHORISATION NUMBER AND DATE: EU/1/19/1400 20191121 |
| 3053913 | 2020/016 | Ireland | ⤷ Sign Up | PRODUCT NAME: NETARSUDIL, OR AN ENANTIOMER, DIASTEREOMER, SALT OR SOLVATE THEREOF; REGISTRATION NO/DATE: EU/1/19/1400 20191121 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
